NEU 1.39% $1.42 neuren pharmaceuticals limited

Breakthrough Therapy Status

  1. gxb
    1,051 Posts.
    lightbulb Created with Sketch. 2
    We all know within 30 days the FDA will make an announcement. NEU have applied for Breakthrough Therapy status and no Australian company has ever been granted BT. Around 30% of BT applications are granted so their is a chance it may not be granted. If this happens I expect some share price weakness however at the same time they will be granted Orphan Drug status for Trofinitide which is just as important but maybe overlooked by the market as the focus will be on the BT. We need to understand sometimes things do not happen as planned thus we cannot panic if BT status is not granted. Lang Walker just purchased options and his holding is at 16% in NEU. I say follow the smart money but we need to be realistic as well.
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Mkt cap $145.7M
Open High Low Value Volume
$1.43 $1.43 $1.39 $81.56K 57.45K

Buyers (Bids)

No. Vol. Price($)
1 2764 $1.40

Sellers (Offers)

Price($) Vol. No.
$1.43 1798 1
Last update - 15.57pm 13/12/2018 (20 minute delay) ?
-0.02 ( 0.00 %)
Open High   Low Volume
$1.43 $1.43   $1.43 1654
Last updated 10.32am 13/12/2018 (live) ?
NEU (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.